Beta Cell Technologies (Beta Cell) is an emerging biotech company located in Adelaide, South Australia, founded by Professor Toby Coates, Professor John Greenwood AM and Mr Julian Burton OAM. Beta Cell is committed to developing pioneering methodologies to treat endocrine deficiency disorders, such as type 1 diabetes (T1D), and is now in the early stages of designing, developing and implementing a novel, Intracutaneous Ectopic (IEP) Pancreas to treat T1D on a global scale.